Abbott Missed Expectations

Abbott (ABT) reported earnings of $1.09 per share on revenue of $10.36 billion for the first quarter ended March 2025. The consensus earnings estimate was $1.07 per share on revenue of $10.42 billion. The Earnings Whisper number was $1.13 per share. The company missed expectations by 3.54% while revenue grew 3.95% on a year-over-year basis.

The company said it continues to expect 2025 earnings of $5.05 to $5.25 per share. The current consensus earnings estimate is $5.15 per share for the year ending December 31, 2025.

Abbott Laboratories discovers, develops, manufactures and sells health care products. Its products include branded generic pharmaceuticals manufactured internationally, marketed and sold outside the United States.